Reliable information for cancer control in Cali, Colombia
Article Sidebar
Main Article Content
Background: The Cali Population Cancer Registry (RPCC) has been in continuous operation since 1962 with the objective of producing valid statistics on the incidence of cancer, its patterns, trends and survival rates.
Methods: During the period 2008-2012, 23,046 new cases were registered and during 2011-2015 there were 12,761 cancer deaths. The trend of the rates was described with the APC average annual change rate and with the Joinpoint analysis. We analyzed the individual data of 38,671 adults (15-99 years) diagnosed with cancer between 1995-2009, and we calculated the standardized net survival by age for the 14 most common cancer body sites, using the Pohar-Perme method.
Results: Prostate and breast cancer were the first cause of cancer morbidity. The incidence rates in these susceptible to early detection, tumors stabilized after decades of growth, while an increase in the incidence of colon cancer and papillary thyroid carcinoma was observed. The incidence rates of cervical and stomach cancer, conditions related to infectious agents, decreased, although the number of absolute cases increased, due to the growth and aging of the population. Gastric cancer was responsible for the highest number of cancer deaths. The types of cancer related to tobacco consumption (lung, oral cavity, esophagus, pancreas, urinary bladder) showed low numbers and a tendency to decrease. During the period 2000-2004, the 5-year net survival improved for cancers of the breast, cervix, prostate, melanoma and thyroid, although in the period 2005-2009 a stagnation was observed. In stomach, liver and lung cancer, the 5-year net survival was less than 15%. The 5-year overall survival in children was 51.0% (95% CI: 47.5, 54.3) and in adolescents 44.6% (95% CI: 36.0, 52.8).
Comment: RPCC has been an advisor to the Colombian government in the evaluation of CPRs in the country and its data have contributed significantly to different aspects of cancer control in Colombia.
- Cancer registry
- incidence
- mortality
- survival
- methods
- Cali
- Colombia
Townsend JS, Moore AR, Mulder TN, Boyd M. What does a Performance Measurement System Tell Us about the National Comprehensive Cancer Control Program? J Publ Health managem Practice. 2015;21(5):449-458. doi:10.1097/PHH.0000000000000124. DOI: https://doi.org/10.1097/PHH.0000000000000124
Bray F, Znaor A, Cueva P, Korir A, Swaminathan R, Ullrich A, et al. Planning and developing population-based cancer registration in low- and middle-income settings. IARC Technical Publications; 43. Lyon: France, 2015. Available from: http://www.iarc.fr/en/publications/pdfs-online/treport-pub/treport-pub43/IARC_Technical_Report_No43.pdf
Pardo C, Cendales R. Cancer incidence estimates and mortality, five first types of cancer in Colombia 2007-2011. Colomb Med (Cali). 2018; 49(1): 16-22. DOI: https://doi.org/10.25100/cm.v49i1.3596
Plan Decenal para el Control del Cáncer en Colombia, 2012 – 2021. Bogota: Ministerio de Salud y Protección Social - Instituto Nacional de Cancerología, ESE, 2012. Available from: http://www.cancer.gov.co/files/libros/archivos/incidencia1.pdf
Bravo LE, Collazos T, Collazos P, García LS, Correa P. Trends of cancer incidence and mortality in Cali, Colombia. 50 years experience. Colomb Med (Cali). 2012;43(4):246-55. DOI: https://doi.org/10.25100/cm.v43i4.1266
Yepez MC, Jurado DM, Bravo LM, Bravo LE. Incidencia, mortalidad y supervivencia del cáncer en Pasto, Colombia. Colomb Med (Cali). 2018; 49(1): 42-54. DOI: https://doi.org/10.25100/cm.v49i1.3616
Arias-Ortiz N, López-Guarnizo G, Arboleda-Ruiz W. Cancer incidence and mortality in Manizales 2003-2007. Colomb Med (Cali). 2012;43(4):289. DOI: https://doi.org/10.25100/cm.v43i4.1197
Uribe PCJ, Serrano GSE, Hormiga SCM. Cancer incidence and mortality in the Bucaramanga metropolitan area, 2008-2012. Colomb Med (Cali). 2018; 49(1): 73-80. DOI: https://doi.org/10.25100/cm.v49i1.3632
Vargas Moranth R, Navarro Lechuga E. Cancer Incidence and Mortality in Barranquilla, 2008-2012 Colomb Med (Cali). 2018; 49(1): 55-62. DOI: https://doi.org/10.25100/cm.v49i1.3627
Brome BMR, Montoya RDM, Salcedo LA. Cancer Incidence and Mortality in Medellin-Colombia, 2010-20. Colomb Med (Cali). 2018; 49(1): 81-88. DOI: https://doi.org/10.25100/cm.v49i1.3740
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9. DOI: https://doi.org/10.1002/ijc.29210
Cendales R, Pardo C. Colombia death certificate quality. Colomb Med (Cali). 2018; 49(1):121-127 DOI: https://doi.org/10.25100/cm.v49i1.3155
Colombia. Departamento Administrativo Nacional de Estadística. Estimaciones y proyecciones de población periodo 1985-2020. Bogotá: Departamento Administrativo Nacional de Estadística. DANE; 2010.
Cuantos somos Como vamos. Diagnóstico Sociodemográfico de Cali y 10 municipios del Pacífico nariñense. Departamento Administrativo Nacional de Estadística DANE - Equipo de Grupos Étnicos de la Dirección de Censos y Demografía. Cali: Afroamericana XXI, 2011.
Pan American Health Organization. Health in the Americas: 2012 Edition. Regional Outlook and Country Profiles. Washington, DC: PAHO, 2012.
Suarez MA, Aguilera J, Salguero EA, Wiesner C. Offer of pediatric oncology services in child cancer care centers in Colombia. Colomb Med (Cali). 2018; 49(1): 97-101. DOI: https://doi.org/10.25100/cm.v49i1.3377
Correa P, Llanos G. Morbidity and mortality from cancer in Cali, Colombia. J Natl Cancer Inst. 1966;36(4):717-45. DOI: https://doi.org/10.1093/jnci/36.4.717
García LS, Bravo LE, Collazos P, Ramírez O, Carrascal E, Nuñez M, Portilla N, Millán E. Methods and procedures of the Population-Based Cancer Registry of Cali, Colombia. Colomb Med (Cali). 2018; 49(1): 109-120. DOI: https://doi.org/10.25100/cm.v49i1.3853
Ramirez O, Aristizabal P, Zaidi A, Ribeiro, R. C., Bravo, LE, VIGICANCER Working Group. Implementing a childhood cancer outcomes surveillance system within a population-based cancer registry. J Global Oncol. 2018; 4:1-11. DOI: https://doi.org/10.1200/JGO.17.00193
Bravo LE, García LS, Collazos P, Aristizabal P, Ramirez O. Descriptive epidemiology of childhood cancer in Cali, Colombia 1977-2011. Colomb Med (Cali). 2013;44(3):155-164. DOI: https://doi.org/10.25100/cm.v44i3.1243
Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer. Cancer. 2005; 103(7): 1457-67. DOI: https://doi.org/10.1002/cncr.20910
Bravo L, García L, Collazos P. Cancer survival in Cali, Colombia: A population-based study, 1995-2004. Colomb Med (Cali). 2014; 3: 110-16. DOI: https://doi.org/10.25100/cm.v45i3.1525
Sanz C. Out-of-Sync Cancer Care: Health Insurance Companies, Biomedical Practices, and Clinical Time in Colombia. Med Anthropol. 2017;36(3):187-201. DOI: 10.1080/01459740.2016.1267172. DOI: https://doi.org/10.1080/01459740.2016.1267172
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977-1010. DOI: https://doi.org/10.1016/S0140-6736(14)62038-9
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018; 391(10125): 1023-1075 DOI: https://doi.org/10.1016/S0140-6736(17)33326-3
Gelband H, Sloan FA, eds. Cancer control opportunities in low-and middle-income countries. National Academies Press. 2007.
Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Prevention Biomarkers. 2016; 25(1): 16-27. DOI: https://doi.org/10.1158/1055-9965.EPI-15-0578
Piazuelo MB, Correa P. Gastric cancer: overview. Colomb Med (Cali). 2013; 44(3):192-201. DOI: https://doi.org/10.25100/cm.v44i3.1263
Muñoz N, Bravo LE. Epidemiology of cervical cancer in Colombia. Colomb Med (Cali). 2012;43(4):298-304. DOI: https://doi.org/10.25100/cm.v43i4.1269
IARC Helicobacter pylori Working Group. Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer. Lyon, France: International Agency for Research on Cancer (IARC Working Group Reports, No. 8); 2014. Available from: http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/index.php
Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, et al. Gastric Cancer as Preventable Disease. Clin Gastroenterol Hepatol. 2017; 15(12):1833-1843. doi: 10.1016/j.cgh.2017.05.023. DOI: https://doi.org/10.1016/j.cgh.2017.05.023
Pisani P, Oliver WE, Parkin DM, Alvarez N, Vivas J. Case-control study of gastric cancer screening in Venezuela. Br J Cancer. 1994; 69(6):1102-5. DOI: https://doi.org/10.1038/bjc.1994.216
Rosero-Bixby L, Sierra R. X-ray screening seems to reduce gastric cancer mortality by half in a community-controlled trial in Costa Rica. Br J Cancer. 2007;97(7):837-43. DOI: https://doi.org/10.1038/sj.bjc.6603729
Llorens P. Gastric cancer mass survey in Chile. Semin Surg Oncol. 1991;7(6):339-43. DOI: https://doi.org/10.1002/ssu.2980070604
Sugano K. Prevention of gastric cancer: urgent need to implement Helicobacter pylori eradication therapy as a primary preventive measure in Japan. J Gastroenterol. 2007;42 Suppl 17:1-2. DOI: https://doi.org/10.1007/s00535-006-1941-8
Sugano K. Strategies for Prevention of Gastric Cancer: Progress from Mass Eradication Trials. Dig Dis. 2016;34(5):500-4. DOI: https://doi.org/10.1159/000445229
Aristizabal N, Cuello C, Correa P, Collazos T, Haenszel W. The impact of vaginal cytology on cervical cancer risks in Cali, Colombia. Int J Cancer. 1984;34(1):5-9. DOI: https://doi.org/10.1002/ijc.2910340103
Palacios R. Considerations on immunization anxiety-related reactions in clusters. Colomb Med (Cali). 2014; 45(3): 136-140. DOI: https://doi.org/10.25100/cm.v45i3.1711
Restrepo J. A., Bravo L. E., García-Perdomo H. A., García L. S., Collazos P., Carbonell J. Incidencia, mortalidad y supervivencia al cáncer de próstata en Cali, Colombia, 1962-2011. Salud Pública Mex. 2014; 56: 440-447. DOI: https://doi.org/10.21149/spm.v56i5.7369
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer. Disponible en: http://publications.iarc.fr/Databases/Iarc-Cancerbases/Globocan-2012-Estimated-Cancer-Incidence-Mortality-And-Prevalence-Worldwide-In-2012-V1-0-2012.
Cortes A, Bravo LE, García LS, Collazos P. Incidencia, mortalidad y supervivencia por cáncer colorrectal en Cali, Colombia, 1962-2012. Salud Pública Mex. 2014;56(5):457-464. DOI: https://doi.org/10.21149/spm.v56i5.7371
Bosetti C, Malvezzi M, Chatenoud L, Negri E, Levi F, La Vecchia C. Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol. 2005; 16(3): 489-511. DOI: https://doi.org/10.1093/annonc/mdi086
Menezes A, Lopez M, Hallal P, Muiño A, Perez-Padilla R, Jardim J. Prevalence of smoking and incidence of initiation in the Latin American adult population: the PLATINO study. BMC Pub Health. 2009; 9: 151. DOI: https://doi.org/10.1186/1471-2458-9-151
Perme M, Stare J, Estève J. On estimation in relative survival. Biometrics. 2012;68:113-120 DOI: https://doi.org/10.1111/j.1541-0420.2011.01640.x
Clerc-Urmès I, Grzebyk M, Hédelin G. Net survival estimation with stns. Stata J. 2014; 14(1):87-102. DOI: https://doi.org/10.1177/1536867X1401400107
Danieli C, Remontet L, Bossard N, Roche L, Belot A. Estimating net survival: the importance of allowing for informative censoring. Statistics Med. 2012;(31):775-786. DOI: https://doi.org/10.1002/sim.4464
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977; 33(1):159-174. DOI: https://doi.org/10.2307/2529310
Kellie SJ, Howard SC: Global child health priorities: What role for paediatric oncologists?. Eur J Cancer. 2008; 44(16):2388-2396 DOI: https://doi.org/10.1016/j.ejca.2008.07.022
Rodriguez-Galindo C, Friedrich P, Alcasabas P, Antillon F, Banavali S, Castillo L, et. al. Toward the cure of all children with cancer through collaborative efforts: pediatric oncology as a global challenge. J Clin Oncol. 2015;33(27):3065. DOI: https://doi.org/10.1200/JCO.2014.60.6376
Magrath I, Steliarova-Foucher E, Epelman S, Ribeiro RC, Harif M, Li CK, et. al. Paediatric cancer in low-income and middle-income countries. Lancet Oncol. 2013;14(3):e104-e116. DOI: https://doi.org/10.1016/S1470-2045(13)70008-1
Gatta, G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel, J, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15(1): 35-47. DOI: https://doi.org/10.1016/S1470-2045(13)70548-5
Ward E, DeSantis C, Robbins A, Kohler B, Jemal, A. Childhood and adolescent cancer statistics. 2014; CA Cancer J Clin. 2014;64(2):83-103. DOI: https://doi.org/10.3322/caac.21219
Moreno F, Dussel V, Orellana L. Childhood cancer in Argentina: Survival 2000–2007. Cancer Epidemiol. 2015;39(4): 505-510. DOI: https://doi.org/10.1016/j.canep.2015.04.010
Downloads
- Rodrigo Guerrero, Luis Eduardo Bravo, Edgar Muñoz, Elvia Karina Grillo Ardila, Esteban Guerrero, COVID-19: The Ivermectin African Enigma , Colombia Medica: Vol. 51 No. 4 (2020): Damage Control Surgery (I)
- Luis Eduardo Bravo, Armando Cortés, Edwin Carrascal, Roberto Jaramillo, Luz Stella García, Paco Eduardo Bravo, Aníbal Badel, Pablo Andrés Bravo, Helicobacter pylori: patología y prevalencia en biopsias gástricas en Colombia. , Colombia Medica: Vol. 34 No. 3 (2003)
- Luis Eduardo Bravo, Nubia Muñoz, Epidemiology of cancer in Colombia , Colombia Medica: Vol. 49 No. 1 (2018): Colombia Cancer Epidemiology
- Luis Eduardo Bravo Ocaña, Paola Collazos, Elvia Karina Grillo Ardila, Luz Stella García, Erquinovaldo Millán, Patricia Mera, Jorge Holguín, Mortality from respiratory infections and chronic non-communicable diseases before the COVID-19 pandemic in Cali, Colombia. , Colombia Medica: Vol. 51 No. 2 (2020): Coronavirus disease 2019
- Luis Eduardo Bravo, Luz Stella Garcia, Paola Collazos, Edwin Carrascal, Elvia Karina Grillo-Ardila, Erquinovaldo Millan, Jorge Holguín, Cancer epidemiology in Cali, 60 years of experience , Colombia Medica: Vol. 53 No. 1 (2022): Cancer incidence and mortality
- Armando Cortés, Wilson Wedekin, Fabiola Bolaños, Reanimación con glóbulos rojos Rh positivo y sin prueba cruzada en emergencias médicas. , Colombia Medica: Vol. 35 No. 4 (2004)
- Armando Cortés, Edgar Flor, Germán Duque, Análisis de costos de la atención médica hospitalaria Experiencia en una clínica privada de nivel II-III. , Colombia Medica: Vol. 33 No. 2 (2002)
- Armando Cortés, Jaime E. Olaya, Giovanna Figueredo, Transfusión ambulatoria y domiciliaria: una alternativa de terapia extrahospitalaria. Experiencia de 9 años en un banco de sangre regional en Cali . , Colombia Medica: Vol. 33 No. 1 (2002)
- Luis Eduardo Bravo, From printing to Scielo and Pubmed Central , Colombia Medica: Vol. 45 No. 1 (2014)
- Luz Stella Garcia, Luis Eduardo Bravo, Paola Collazos, Oscar Ramirez, Edwin Carrascal, Marcela Nuñez, Nelson Portilla, Erquinovaldo Millan, Cali Cancer Registry Methods , Colombia Medica: Vol. 49 No. 1 (2018): Colombia Cancer Epidemiology
Similar Articles
- Luis Eduardo Bravo, Juliana Alexandra Hernández Vargas, Paola Collazos, Luz Stella García, Ana María Valbuena, Lizbeth Acuña, Survival in stomach cancer: analysis of a national cancer information system and a population-based cancer registry in Colombia , Colombia Medica: Vol. 53 No. 4 (2022): The death debate
- Luis Eduardo Bravo, Luz Stella Garcia, Paola Collazos, Edwin Carrascal, Elvia Karina Grillo-Ardila, Erquinovaldo Millan, Jorge Holguín, Cancer epidemiology in Cali, 60 years of experience , Colombia Medica: Vol. 53 No. 1 (2022): Cancer incidence and mortality
- Luis Gabriel Parra-Lara, Juan Pablo Arango-Ibañez, Juan Jose Martinez-Arboleda, Juan Carlos Bravo, Ángela R. Zambrano, Paola Collazos, Francisco Andino, Angelica Badillo, Sebastian Estrada, Fernando Rosso, Survival of patients living with HIV and cancer in Cali, Colombia , Colombia Medica: Vol. 54 No. 3 (2023)
- Luis Eduardo Bravo, Luz Stella García, Paola Andrea Collazos, Cancer survival in Cali, Colombia: A population-based study, 1995-2004 , Colombia Medica: Vol. 45 No. 3 (2014)
- Luis Eduardo Bravo, Nubia Muñoz, Epidemiology of cancer in Colombia , Colombia Medica: Vol. 49 No. 1 (2018): Colombia Cancer Epidemiology
- Luis Eduardo Bravo, Luz Stella Garcia, Paola Collazos, Jorge Alirio Holguin, Isabelle Soerjomataram, Adalberto Miranda-Filho, Trends in long-term cancer survival in Cali, Colombia: 1998-2017 , Colombia Medica: Vol. 53 No. 1 (2022): Cancer incidence and mortality
You may also start an advanced similarity search for this article.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use